CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- Open-market buys, last 90 days
- $238,371
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Vivo Opportunity, LLC 10% owner | Purchase | +6,125 | $1.57 | $10K | 638,960 |
| 2026-06-04 | Vivo Opportunity, LLC 10% owner | Purchase | +618 | $1.57 | $970 | 64,508 |
| 2026-06-03 | Vivo Opportunity, LLC 10% owner | Purchase | +7,069 | $1.55 | $11K | 632,835 |
| 2026-06-03 | Vivo Opportunity, LLC 10% owner | Purchase | +714 | $1.55 | $1K | 63,890 |
| 2026-06-02 | Vivo Opportunity, LLC 10% owner | Purchase | +20,753 | $1.52 | $32K | 625,766 |
| 2026-06-02 | Vivo Opportunity, LLC 10% owner | Purchase | +2,095 | $1.52 | $3K | 63,176 |
| 2026-06-01 | Vivo Opportunity, LLC 10% owner | Purchase | +14,838 | $1.55 | $23K | 605,013 |
| 2026-06-01 | Vivo Opportunity, LLC 10% owner | Purchase | +1,498 | $1.55 | $2K | 61,081 |
| 2026-05-29 | Vivo Opportunity, LLC 10% owner | Purchase | +16,164 | $1.57 | $25K | 590,175 |
| 2026-05-29 | Vivo Opportunity, LLC 10% owner | Purchase | +1,632 | $1.57 | $3K | 59,583 |
| 2026-05-21 | Vivo Opportunity, LLC 10% owner | Purchase | +30,882 | $1.69 | $52K | 574,011 |
| 2026-05-21 | Vivo Opportunity, LLC 10% owner | Purchase | +3,118 | $1.69 | $5K | 57,951 |
| 2026-05-20 | Vivo Opportunity, LLC 10% owner | Purchase | +51,056 | $1.56 | $80K | 543,129 |
| 2026-05-20 | Vivo Opportunity, LLC 10% owner | Purchase | +5,154 | $1.56 | $8K | 54,833 |
| 2026-05-19 | ADAR1 Capital Management, LLC 10% owner | Purchase | +68,551 | $1.60 | $110K | 400,000 |
| 2026-05-19 | ADAR1 Capital Management, LLC 10% owner | Purchase | +200,000 | $1.56 | $312K | 600,000 |
| 2026-05-19 | ADAR1 Capital Management, LLC 10% owner | Purchase | +200,000 | $1.50 | $300K | 800,000 |
| 2025-12-19 | Johnson Shane Aaron Sr VP & General Manager | Grant or award · Employee Stock Option (Right to Buy) | +8,500 | 12,400 | ||
| 2025-12-19 | Lemerond Nicole Director | Grant or award · Employee Stock Option (Right to Buy) | +1,750 | 2,725 | ||
| 2025-12-19 | Klompas Neil A Director | Grant or award · Employee Stock Option (Right to Buy) | +1,750 | 5,250 |
Page 3 of 8 · 149 trades